Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.

Patrick MarcellinDavid K WongWilliam SievertPeter BuggischJörg PetersenRobert FlisiakMichael MannsKelly KaitaZahari KrastevSamuel S LeeAndrea L CathcartGerald CransMarjoleine Op den BrouwBelinda JumpAnuj GaggarJohn FlahertyMaria Buti

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

Over 10 years, TDF had a favourable safety profile, was well tolerated, and resulted in continued maintenance of virological suppression with no documented resistance.

Keyphrases

antiretroviral therapy
hiv infected
replacement therapy
smoking cessation